• 05.10.12

    Time to Put Your 10-K on a Diet

    Another Form 10-K Annual Report filing season has ended for most U.S. banking organizations.This means that publicly traded banks and bank holding companies have filed 10-Ks with Supervision and Regulation ("Sup & Reg") sections, along with a corresponding set of regulatory risk factors, which ...

  • 05.08.12

    FDA Regulation of 'Cosmeceuticals:' More Wrinkles Coming?

    Compared to other popular direct response product categories, such as dietary supplements, over-the-counter drugs (e.g., anti-acne creams) and medical devices (e.g., wrinkle and acne reducing lights), cosmetics are subject to far less Food and Drug Administration (FDA) regulation. Unlike those ...

  • 05.03.12

    Eliminate All Incentive Compensation

    Arnold Schwarzenegger said, when he was first elected as governor of California, that he wanted to "blow up the boxes" of the state bureaucracy.The ongoing challenges presented by executive compensation, methods of paying executive compensation and inherent risks associated with certain ...

  • 05.03.12

    Health Reform – Genie Is Out of the Bottle

    The cherry-picking of harsh Supreme Court questions about the Affordable Care Act has fed a misleading impression that health reform is on life support or perhaps already deceased. Here’s the reality -- health reform continues. Virtually every state is now engaged in using federal grants to ...

  • 04.24.12

    Planning to Manage the Renewable Generation Gap: the 'Nudge' vs. the 'Shove'

    Manatt partner David Huard, chair of the firm’s Energy, Environment and Natural Resources practice group, authored an article, “Planning to Manage the Renewable Generation Gap: the ‘Nudge’ vs. the ‘Shove’,” for the September 17, 2010, edition of BNA Daily ...

  • 04.24.12

    Health Reform Accelerates Changes in the Pharmaceutical Industry

    The Patient Protection and Affordable Care Act makes major changes to the Medicare prescription drug benefit, reducing drug costs for many seniors and increasing rebates and other costs for industry. Although these changes will affect prescription drug costs and pharmaceutical companies’ ...

  • 04.24.12

    The Best Defense May Be a Good Offense

    Defending a class action lawsuit poses great risk and uncertainty for a corporate defendant. A single plaintiff, whose claims may be worth only a pittance standing alone, can represent the claims of every corporate customer over a period of several years. If the court refuses to certify the class, ...

  • 04.23.12

    Is Anyone Not a Foreign Official Under the FCPA?

    Recent years have seen a rise in the number of enforcement actions taken by the Department of Justice (DOJ) and the Securities Exchange Commission (SEC) under the Foreign Corrupt Practices Act (FCPA), as well as a notable expansion of the types of conduct covered by these prosecutions. ...

  • 04.23.12

    New Trend in Sustainable HIEs: Fair Share Financial Support

    CMS recently solidified a new trend in electronic health information exchange sustainability: requiring all stakeholders who stand to benefit from electronic HIE to share in a portion of its costs. It seems like common sense, but a scan of HIE initiatives reveals that HIE traditionally has been ...



pursuant to New York DR 2-101(f)

© 2023 Manatt, Phelps & Phillips, LLP.

All rights reserved